We have proposed novel alkylglycosides, AGs, that consist of an isoprenoid-type hydrophobic chain, the 3,7,11,15-tetramethylhexadecyl (phytanyl) group. One notable feature of the proposed AGs lies in the fact that their Krafft eutectic temperatures, T K, are well below room temperature although the total number of carbon atoms in the hydrophobic chain is as large as 20. As compared to the conventional AGs with straight and saturated alkyl chains, their low T K values significantly expand our freedom to control their aqueous phase structures at low temperatures. The aqueous phase structures are controlled by modification of the headgroup: an H II phase for the glycerol headgroup, a cubic phase with crystallographic space group Pn 3 m / Pn 3 at low temperatures and an H II phase at higher temperatures for a xylose headgroup, and an L α phase for a glucose and a maltose headgroup.
No takes yet. Share an insight, caveat, or question.
Hato et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: